[pdf] patents office journal - Irish Patents Office

811
(05/04/2006) Patents Office Journal (No. 2043)
Request for Grant of Supplementary Protection Certificate
The name and address of the requestor follow the number allocated to the request. The date in brackets
following the name and address is the date of receipt of the request. The Patent number is that under which
the product in respect of which a certificate is sought is, allegedly, protected. Market Authorisation
references in respect of the product concerned are also shown.
2006009 LES LABORATOIRES SERVIER, 22 rue Garnier, 92200 Neuillysur-Seine,
France
(1 March 2006)
Patent No: 0534859; Benzocyclobutyl- or indanyl-alkyl-amino-alkyl
substituted 3-benzazepin-2-ones useful in the treatment of
cardiovascular diseases
Product: Procoralan - Ivabradine
Market Authorisation: Ireland EU/1/05/316/001-014, 25/10/2005
Supplementary Protection Certificates Granted
The name and address of the grantee follows the number allocated to the application for grant of a certificate;
this number applies also to the granted certificate. The date in brackets following the name and address is the
date of grant of the certificate. The number of the basic Patent and the title of the invention are followed by
the name of the product for which the certificate is granted. Market authorisation references in respect of the
product concerned are also shown, followed by the date of expiry of the certificate.
2002032 E.I. du Pont de Nemours and Company, Wilmington, Delaware 19898, United
States of America
10/03/2006
Patent No: 66407; Fungicidal oxazolidinones
Product: A formulation comprising a mixture of famoxadone and cymoxanil
Market Authorisation: Ireland AP01398, 14/05/2002
Switzerland 5665, 11/12/1997
Certificate Expires on: 10/12/2012
2005002 ELI LILLY AND COMPANY, Lilly Corporate Center, Indianapolis, Indiana
46285, United States of America
08/03/2006
Patent No: 60805; 3-Aryloxy-3-substituted propanamines
Product: duloxetine and pharmaceutically acceptable acid addition salts thereof,
and in particular, duloxetine hydrochloride
Market Authorisation: Ireland EU/1/04/280/001-006, 11/08/2004
Certificate Expires on: 17/12/2012
2005003 MERCK FROSST CANADA & CO., Purdy`s Wharf Tower One, 1959 Upper
Water Street, P.O. Box 997, Halifax, Nova Scotia B3J 2X2, Canada
08/03/2006
Patent No: 0863891; (Methylsulfonyl)phenyl-2-(5H)-furanones as cox-2